Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol with sevoflurane anesthesia in elderly digestive tract tumor surgery
ChiCTR2200063246Phase 4Not yet recruiting
- Sponsor
- Yongchuan Hospital Affiliated to Chongqing Medical University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in gastrointestinal stromal tumor (GIST) (2 arms), sponsored by Yongchuan Hospital Affiliated to Chongqing Medical University. Primary endpoints: Mean arterial pressure, Heart rate and 4 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR2200063246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063246.